abemaciclib,panitumumab
eli lilly,amgen,takeda
[]
i endorse this thoughtful paradigm from dr claudine issacs. recommend the postmonarch trial to answer the final question on extending cdk4/6 inhibitors #asco22 
Director Breast Oncology, Lifespan Cancer Institute, Legorreta Cancer Center Brown Univ | Medical Advisor @drloveresearch | #bcsm #clinicaltrials | Views Mine